📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. (2019)

First Author: Fultang L

Attributed to: UNDERSTANDING THE ROLE OF EPSTEIN BARR VIRUS IN T CELL AND NATURAL KILLER CELL LYMPHOPROLIFERATIONS AND MALIGNANCIES funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2019.08.025

PubMed Identifier: 31462392

Publication URI: http://europepmc.org/abstract/MED/31462392

Type: Journal Article/Review

Volume: 47

Parent Publication: EBioMedicine

ISSN: 2352-3964